REGASK SPONSORS
RAPS Atlanta Chapter 2025: CTRL + ALT + REGULATE
OCTOBER 27, 2025 | Roswell, Georgia
StimLabs (Roswell, GA)
Meet our team
Join Deanna Coscia, Senior Vice President, Commercial, and Kelli Madden, Senior Regulatory Intelligence Manager as they represent RegASK at the RAPS Atlanta Chapter In-Person Event: CTRL + ALT + REGULATE.
Connect with our team to explore how AI-driven regulatory intelligence is transforming compliance and discover how RegASK empowers smarter, faster regulatory decisions in today’s evolving life sciences landscape.
Deanna Coscia
SVP, Commercial
Kelli Madden
Senior Regulatory Intelligence Manager
CTRL + ALT + REGULATE: Redefining Regulatory Affairs with AI
The RAPS Atlanta Chapter In-Person Event, CTRL + ALT + REGULATE, is an exclusive gathering that brings together regulatory professionals, industry leaders, and innovators to explore how AI is transforming regulatory affairs.
This full-day program will dive into how AI-driven tools are reshaping compliance strategies, risk management, and global-to-local regulatory alignment, empowering professionals to accelerate decision-making and future-proof their organizations.
Key themes include:
- Redefining regulatory affairs through AI and digital transformation
- Real-world case studies of AI adoption in compliance and risk management
- Addressing ethical, security, and trust considerations in AI integration
- Practical strategies for regulatory professionals to leverage AI in daily workflows
- Networking with experts and peers shaping the future of regulatory innovation
Venue & Schedule:
📍 StimLabs, Roswell, Georgia
🗓 Monday, October 27, 2025 | 08:00 AM – 05:30 PM ET
What RegASK Brings to CTRL + ALT + REGULATE
At RegASK, we’re shaping the future of regulatory affairs with AI-driven intelligence and workflow orchestration. We help organizations track evolving regulations, streamline global-to-local workflows, anticipate risks, and accelerate compliance decisions with accuracy and speed.
🎙 Speaking Session
Kelli Madden, Senior Regulatory Intelligence Manager at RegASK
🕒 3:15 PM — “Cautions and Watchouts When Using AI in RAQ”
Gain insights on the risks, limitations, and best practices for responsible AI use in regulatory affairs.
Don’t miss this insightful session to gain a deeper understanding of how to leverage AI responsibly while ensuring trust, transparency, and compliance in regulatory processes.
Our solution
RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.
RegGenius
Harness the power of AI to gain a competitive edge in regulatory compliance.
RegAlert
No surprises with automated regulatory monitoring.
RegInsights
Identify trends, anticipate risks, and build better strategies.
Ask RegASK
Access to our community of regulatory subject matter experts.
Resources
Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more